证券代码：300967 证券简称：晓鸣股份 宁夏晓鸣农牧股份有限公司 投资者关系活动记录表 编号：2023-001 | 投资者关系活动类别 | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 ☐业绩说明会 | | | ☐新闻发布会 路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 形式 | ☐现场 网上 ☐电话会议 | | 参与单位名称及人员姓名 | 线上参与公司发行可转债网上路演活动的投资者 | | 时间 | 2023年04月04日 15:00-17:00 | | 地点 | 价值在线（https://www.ir-online.cn） | | | 魏晓明 董事长兼总经理； 杜建峰 副总经理兼董事会秘书； | | | 孙灵芝 财务总监； | | 上市公司接待人员姓名 | 杜国文 华西证券股份有限公司副总裁、晓鸣股份保荐代表人； | | | 尹玉堂 华西证券股份有限公司消费行业组高级副总裁、晓鸣股 | | 1. | 份保荐代表人。 贵司产品在国内市场占有率为多少？如何进一步扩大市率？ | | | 答:尊敬的投资者您好！公司目前是中国规模 ...

证券代码：300967 证券简称：晓鸣股份 宁夏晓鸣农牧股份有限公司 投资者关系活动记录表 编号：【2021】第 004 号 | --- | --- | --- | |-------------------------|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------| | | | | | | 特定对象调研 | □分析师会议 | | 投资者关系活 | □媒体采访 | 业绩说明会 | | 动类别 | □新闻发布会 | 路演活动 | | | 现场参观 | □其他 | | 参与单位名称 及人员姓名 | 海通证券 景泰利丰基金 广州金控投资 等 | 丁频、孟亚琦、上官灵芝、陈阳；海通投行 裘敏杰； 吕伟志；西部利得基金 曹永斌；亚太财险 石改； 黄勇；淡水泉投资 黄凯锐；沪光 SIIC 吴滨； | | 时 间 | 20 ...

编号：【2021】第 003 号 证券代码：300967 证券简称：晓鸣股份 宁夏晓鸣农牧股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------------------------|-------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | √特定对象调研 | □分析师会议 | | 投资者关系活 | □媒体采访 | □业绩说明会 | | 动类别 | □新闻发布会 | □路演活动 | | | √现场参观 | □其他 | | 参与单位名称 及人员姓名 | 参会人员：海通 ...

编号：【2021】第 005 号 证券代码：300967 证券简称：晓鸣股份 宁夏晓鸣农牧股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------------------------|--------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | 特定对象调研 | □分析师会议 | | 投资者关系活 | □媒体采访 | 业绩说明会 | | 动类别 | □新闻发布会 | 路演活动 | | | 现场参观 | □其他 | | 参与单位名称 及人员姓名 | 天风证券 保险 ...

Financial Performance - The company's revenue for Q3 2022 was ¥180,780,455.62, an increase of 0.66% year-over-year, while the year-to-date revenue reached ¥562,718,292.59, up by 5.40%[5] - The net profit attributable to shareholders for Q3 2022 was a loss of ¥3,343,807.00, a decrease of 113.31% compared to the same period last year, with a year-to-date net profit of ¥17,879,756.08, down by 76.80%[5] - The basic and diluted earnings per share for Q3 2022 were both -¥0.018, reflecting a decline of 113.43% year-over-year, while the year-to-date earnings per share were ¥0.095, down by 79.48%[5] - Total operating revenue for the third quarter of 2022 was CNY 562,718,292.59, an increase from CNY 533,867,246.49 in the same period last year, representing a growth of approximately 5.3%[22] - The company's net profit margin for the third quarter of 2022 was approximately 0.7%, compared to a higher margin in the previous year due to increased costs[22] - The net profit for Q3 2022 was CNY 17,879,756.08, a decrease from CNY 77,066,743.44 in the same period last year, representing a decline of approximately 76.8%[23] - Operating profit for Q3 2022 was CNY 8,120,648.05, compared to CNY 64,838,301.43 in Q3 2021, indicating a significant drop of about 87.5%[23] Assets and Liabilities - The total assets as of September 30, 2022, were ¥1,382,104,244.40, representing a 19.00% increase from the end of the previous year[5] - Current assets decreased to CNY 184,955,538.41 from CNY 292,998,439.08, a decline of approximately 36.9%[20] - Non-current assets increased to CNY 1,197,148,705.99 from CNY 868,423,984.68, showing a growth of about 37.8%[20] - The total liabilities increased to CNY 573,899,991.33 from CNY 336,054,336.97, representing a rise of approximately 70.7%[20] - The company's equity attributable to shareholders decreased to CNY 808,204,253.07 from CNY 825,368,086.79, a decline of approximately 2.1%[21] Cash Flow - Cash flow from operating activities for the year-to-date was ¥83,586,554.13, a decrease of 36.75% compared to the previous year[13] - Cash flow from operating activities for the current period was CNY 83,586,554.13, down from CNY 132,155,681.82 in the previous year, a decrease of approximately 36.7%[24] - Cash flow from investing activities showed a net outflow of CNY 368,787,546.17, compared to a net outflow of CNY 104,705,825.94 in the previous year, indicating a significant increase in investment expenditures[25] - Cash flow from financing activities resulted in a net inflow of CNY 169,738,835.52, compared to a net inflow of CNY 138,541,105.29 in the same period last year, representing an increase of approximately 22.5%[25] - The ending cash and cash equivalents balance was CNY 55,993,346.58, a decrease from CNY 209,524,624.18 at the end of the previous year, indicating a decline of about 73.2%[25] Investments and Expenses - The company reported a significant increase in construction in progress, which rose by 449.07% to ¥192,001,645.41, primarily due to investments in the Southern Seed Industry Center and the Hongsi Fort Smart Agriculture Demonstration Park[9] - The company's other non-current assets increased by 299.77% to ¥53,692,237.74, attributed to increased prepayments for project construction and equipment[9] - The company reported a research and development expense of CNY 20,048,348.93 for the third quarter, compared to CNY 17,417,064.73 in the previous year, indicating an increase of about 9.4%[22] - The company’s management expenses decreased by 37.52% to ¥15,352,600.78, mainly due to the absence of listing-related expenses and bonuses from the previous year[11] Shareholder Information - The total number of common shareholders at the end of the reporting period is 15,890[14] - The largest shareholder, Wei Xiaoming, holds 42.14% of the shares, totaling 80,160,000 shares[14] - The second-largest shareholder, Chia Tai Investment Co., Ltd., holds 11.87% of the shares, totaling 22,580,000 shares[14] - The total number of shares held by the top ten unrestricted shareholders amounts to 66,000,000 shares[15] - The company has a total of 0 preferred shareholders with voting rights restored[14] - The company has a total of 6.38% of shares held by other investors, totaling 12,134,100 shares[14] Convertible Bonds - The company has received approval from the Shenzhen Stock Exchange for issuing convertible bonds, with the application being accepted on June 1, 2022[16] - The company is in the process of responding to inquiries from the Shenzhen Stock Exchange regarding the issuance of convertible bonds[16] - The company has completed the first round of inquiries and is preparing for the second round of inquiries regarding the convertible bond issuance[16] - The company is committed to timely information disclosure regarding the progress of the convertible bond issuance[17]

Demand and Market Position - The company reported a stable demand for commodity chicks, maintaining an annual demand of approximately 1.1 billion chicks, with a market share of 14.95% in 2021, selling 173 million chicks[9]. - The company’s market share for commodity chicks was 14.95% in 2021, with sales of 173 million chicks[154]. - The company sold 95.56 million commodity chicks, representing a year-on-year increase of 16.53%[51]. - In 2021, the company sold 173.31 million commercial chicks, a year-on-year increase of 20.10%, achieving a market share of 14.95%, up 19.41% from the previous year, with revenue reaching 714.37 million yuan, a growth of 32.29%[86]. Financial Performance - The company's revenue for the reporting period was approximately ¥381.94 million, representing a 7.81% increase compared to ¥354.27 million in the same period last year[34]. - The net profit attributable to shareholders decreased by 59.15% to ¥21.22 million from ¥51.95 million year-on-year[34]. - The net profit after deducting non-recurring gains and losses fell by 78.29% to ¥9.41 million from ¥43.32 million in the previous year[34]. - The net cash flow from operating activities decreased by 25.24% to ¥68.04 million compared to ¥91.00 million in the same period last year[34]. - Basic and diluted earnings per share dropped by 65.98% to ¥0.1132 from ¥0.3327 year-on-year[34]. - The weighted average return on net assets decreased to 2.54% from 7.53% in the previous year, a decline of 4.99%[34]. Operational Challenges - The company faced significant cost increases due to rising prices of corn and soybean meal, which are critical raw materials for feed production, leading to a decrease in gross margin[6]. - The company has experienced fluctuations in gross margin and net profit due to upstream raw material price volatility and the impact of the COVID-19 pandemic, indicating potential risks of performance decline and losses[12]. - The company is heavily reliant on a single foreign supplier, Hy-Line International, for its breeding stock, which poses a risk if supply is disrupted due to disease or other factors[8]. - The poultry industry is facing challenges from avian diseases, which could significantly impact production and sales, as well as consumer demand for poultry products[5]. - The company’s operational costs are expected to rise due to increased investments in disease prevention measures and the need for emergency immunization in response to potential outbreaks[5]. - The company acknowledges the potential adverse effects of macroeconomic fluctuations and rising commodity prices on its operational performance[157]. Strategic Initiatives - The company plans to enhance its core competitiveness through management and technological innovations, aiming for increased market share and profitability[15]. - The company will accelerate the development of its main business by promoting a standardized operating model of "centralized breeding and decentralized incubation" to reduce expansion costs[15]. - The company intends to increase investment in technology research and development to improve various technical levels, including biosecurity and disease prevention[15]. - The company is actively advancing the Hongshibao Smart Agriculture Industrial Demonstration Park project and the Southern Seed Industry Center project, which are expected to enhance production capacity[52]. - The company is constructing a smart agriculture demonstration park in Ningxia and a southern seed center in Hunan[41]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market reach[190]. Research and Development - The company has established a comprehensive technical and R&D system, including a veterinary center and a livestock center, to support disease control and data analysis[114]. - The company has built a strong technical research and development team, focusing on feed nutrition, disease control, and automated breeding technologies, establishing a competitive advantage in the industry[102]. - The company is collaborating with several research institutions and universities to strengthen its technological support and innovation capabilities[120]. - The company is actively applying for multiple patents related to disease prevention and control in poultry farming, including a detection method for Mycoplasma gallisepticum in large-scale chicken farms[113]. Biosecurity Measures - The company has established a disease prevention system tailored to regional and breed characteristics, which is crucial for minimizing losses from outbreaks[75]. - The company has maintained a strong biosecurity system, with no major animal epidemics reported since its establishment, and is the only enterprise in the egg-laying chicken industry to pass the biosecurity assessment for disease-free zones[97]. - The company employs a "full entry, full exit" biosecurity operation model to effectively prevent disease and pest transmission[95]. - Significant investments have been made in the development of a comprehensive biosecurity manual to guide practices and enhance safety awareness[95]. Social Responsibility and Community Engagement - The company has actively engaged in rural revitalization strategies, aligning agricultural modernization with poverty alleviation efforts[104]. - The company has donated 162,050 chicks worth approximately 71,626.00 CNY to 1,316 low-income households, fulfilling its social responsibility[183]. - The company donated 3,000 medical masks and 3,000 rubber gloves, along with living supplies worth 16,319.54 yuan to support local pandemic prevention efforts[180]. - The company is committed to sustainability initiatives, aiming for a 40% reduction in carbon emissions by 2025[190]. Future Outlook - The company provided a positive outlook for the second half of 2022, projecting a revenue growth of 10% to 12%[190]. - New product launches are expected to contribute an additional 200 million RMB in revenue by the end of the year[191]. - The company is expanding its market presence, targeting a 25% increase in market share in the next fiscal year[190]. - Future guidance includes maintaining a gross margin of 35%, supported by cost control measures and operational efficiencies[200].

Investment and Expansion Plans - The company plans to invest in multiple projects, including the Red Desert Smart Agriculture Industrial Demonstration Park and the Alxa Chicken Breeding Farm, with a focus on enhancing production capacity and economic benefits[11]. - The company plans to continue expanding production capacity and increasing market share as its main operational strategy[66]. - The company signed an investment contract for the Southern Seed Industry Center project in Changde, Hunan, with a planned investment of 150 million RMB, covering an area of 100 acres and establishing two automated incubation production lines[82]. - The company plans to invest 300 million RMB in the Red Silk Fort Smart Agriculture Industrial Demonstration Park project in Wuzhong, Ningxia, which is expected to house 1 million parent stock egg-laying chickens upon completion[82]. - The company has invested in a feed processing plant with an annual output of 200,000 tons in its smart agricultural poverty alleviation industrial park[68]. Financial Performance - The company's operating revenue for 2021 was CNY 714,367,715.43, representing a 32.29% increase compared to CNY 540,018,818.00 in 2020[26]. - The net profit attributable to shareholders for 2021 was CNY 81,845,580.77, a 62.88% increase from CNY 50,248,556.43 in 2020[26]. - The net cash flow from operating activities reached CNY 175,482,675.16, a significant increase of 106.77% compared to CNY 84,866,811.79 in 2020[26]. - The total assets at the end of 2021 were CNY 1,161,422,423.76, reflecting a 32.82% increase from CNY 874,431,397.93 at the end of 2020[26]. - The company achieved operating revenue of 714.37 million yuan, a year-on-year increase of 32.29%[80]. Market and Industry Trends - The poultry industry is experiencing price volatility due to macroeconomic factors and seasonal changes, which could affect the sales prices of products[8]. - The egg production model is shifting towards vertical integration, allowing companies to cover the entire supply chain from breeding to egg production, enhancing operational efficiency[46]. - The cooperative farming model, which connects companies with farmers, is gaining traction, allowing for better control over production quality and stability[48]. - The company anticipates ongoing consolidation in the egg-laying industry, with a trend towards increased market concentration and a shift from small-scale to large-scale farming operations[160]. - The demand for chicken eggs is expected to remain strong, particularly in peak consumption months such as January, February, September, and October[57]. Research and Development - The company is committed to increasing R&D investments to improve biosecurity, disease prevention, and modern farming techniques[12]. - The company has established a research institute for the egg-laying chicken industry and has received approval for 2 key R&D projects in the region[136]. - Continuous investment in R&D focuses on breeding, disease prevention, nutrition, and welfare technologies, with an emphasis on applied technology development[166]. - The company is actively working on the development of new vaccines and treatments for poultry diseases to improve overall industry competitiveness[131]. - The company is exploring partnerships with upstream feed and veterinary companies to create a conducive environment for broiler chicken farming[163]. Biosecurity and Disease Prevention - The company has established a comprehensive disease prevention system, incorporating scientific farm site selection and vaccination measures to mitigate risks[54]. - The company has maintained a strong biosecurity system, with no major animal epidemics such as highly pathogenic avian influenza or Newcastle disease reported since its establishment[92]. - The company has developed a rapid detection technology system for vertically transmitted diseases, which has been implemented and promoted nationwide over the past 10 years[104]. - The company employs "sentinel chickens" for disease monitoring, which are highly sensitive to specific pathogens and provide early warning for potential outbreaks[105]. - The company has established strict quality control standards, ensuring high survival and egg production rates for its chicks[94]. Operational Efficiency and Cost Management - The company employs a two-stage full cage breeding model for commodity layer chickens, with high mechanization and automation levels in newly built facilities[53]. - The company maintains a comprehensive internal control system for procurement, focusing on cost advantages and product quality[74]. - The company reported a 5% reduction in operational costs due to improved supply chain management[9]. - The company is committed to enhancing production efficiency and product quality through standardized and automated production processes[165]. - The company has implemented a comprehensive financial and business integration system, utilizing big data for breeding management[95]. Corporate Governance and Shareholder Relations - The governance structure of the company includes a shareholders' meeting, board of directors, supervisory board, and senior management, ensuring effective operational management[177]. - The company maintains independence from its controlling shareholder, ensuring no interference in decision-making and operational activities[177]. - The company has approved a proposal to issue convertible bonds to unspecified objects, with a focus on raising funds for operational expansion[185]. - The company is committed to maintaining a stable dividend policy, reflecting its confidence in future earnings and cash flow[187]. - The company has established a plan for daily related party transactions for 2021, ensuring compliance and operational efficiency[186]. Customer Engagement and Market Strategy - The company is focused on expanding its market presence and enhancing its product offerings in the agricultural sector[192]. - User data and customer engagement strategies are being prioritized to improve service delivery and customer satisfaction[192]. - The company is exploring acquisition opportunities in the North American market to enhance its product portfolio[7]. - A new strategic partnership was announced, expected to increase market share by 15% over the next year[8]. - The company aims for a stable annual sales growth of approximately 20% while maintaining steady cash flow and increasing revenue and market share[165].

Financial Performance - The company's revenue for Q1 2022 was CNY 188,184,810.50, representing a 27.41% increase compared to CNY 147,696,606.23 in the same period last year[4]. - Net profit attributable to shareholders decreased by 21.23% to CNY 13,643,919.32 from CNY 17,322,243.33 year-on-year[4]. - Basic and diluted earnings per share decreased by 40.65% to CNY 0.073 from CNY 0.123 in the same period last year[4]. - Operating profit for the first quarter was CNY 8,482,061.70, compared to CNY 12,163,602.46 in the prior year, reflecting a decrease of 30.0%[35]. - The total comprehensive income for the first quarter was CNY 13,643,919.32, down from CNY 17,322,243.33 in the same period last year[36]. Cash Flow and Investments - The net cash flow from operating activities fell by 27.31% to CNY 22,294,117.92, down from CNY 30,670,533.72 in the previous year[4]. - The company incurred a cash outflow of CNY 124,129,965.58 from investing activities, compared to CNY 20,696,109.06 in the previous year, indicating a significant increase in investment expenditures[38]. - The company’s operating cash outflow totaled CNY 171,461,044.68, compared to CNY 132,960,645.81 in the previous year, reflecting an increase of 29.0%[38]. - Total cash inflow from financing activities was CNY 58,627,295.00, an increase from CNY 22,000,000.00 in the same period last year[38]. - The company reported cash and cash equivalents at the end of the period amounting to CNY 123,098,644.75, compared to CNY 51,019,767.82 at the end of the previous year[38]. Assets and Liabilities - Total assets increased by 5.92% to CNY 1,230,143,903.20 compared to CNY 1,161,422,423.76 at the end of the previous year[4]. - The total liabilities increased to CNY 389,559,903.89 from CNY 336,054,336.97, reflecting a rise of 15.9%[32]. - The company's equity attributable to shareholders increased to CNY 840,583,999.31 from CNY 825,368,086.79, a growth of 1.8%[33]. Operating Costs - Operating costs rose by 32.94%, attributed to increased sales volume and rising transportation costs[8]. - The total operating costs for the first quarter of 2022 were CNY 181,234,019.71, up 31.4% from CNY 137,894,180.78 in the previous year[34]. - The gross profit margin for the first quarter of 2022 was approximately 3.9%, down from the previous year's margin[34]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 18,427[10]. - The company reported a total of 240,000 shares released from restrictions for Zhu Wanqian, increasing his total holdings to 320,000 shares[13]. - The company announced that 1,000,000 shares were released from restrictions for Shi Yuxin, bringing his total to 1,100,000 shares[15]. - The company indicated that 79,960,000 shares were held by Wei Xiaoming, with an increase of 200,000 shares, totaling 80,160,000 shares[13]. - The company disclosed that 1,124,000 shares were held by Wang Xueqiang, with an increase of 50,000 shares, totaling 1,174,000 shares[13]. Stock Incentive Plans - The company has a stock incentive plan that includes various executives selling shares, with limits set for 2024 and 2025[21]. - The stock incentive plan is part of the company's broader strategy to enhance employee engagement and performance[22][23]. - The company is committed to transparency in its stock incentive program, providing detailed information on allocations and sales[22][23]. - The stock sales are scheduled to occur over a period extending to 2026, suggesting a long-term strategy for employee retention and motivation[22][23]. - The total number of shares involved in the stock incentive plans is significant, with multiple individuals participating, which may impact future share dilution[22][23].

Financial Performance - The company's revenue for Q3 2021 reached ¥179,600,214.36, representing a 23.24% increase compared to the same period last year[3] - Net profit attributable to shareholders was ¥25,115,539.91, a 39.69% increase year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥18,188,571.68, showing a slight increase of 0.76%[3] - Total operating revenue for the third quarter reached CNY 533,867,246.49, an increase of 25.1% compared to CNY 426,621,231.74 in the same period last year[20] - Operating profit amounted to CNY 64,838,301.43, up 23.1% from CNY 52,679,371.16 year-on-year[21] - Net profit attributable to the parent company was CNY 77,066,855.95, representing a growth of 53.4% compared to CNY 50,201,169.41 in the previous year[22] - Basic and diluted earnings per share increased to CNY 0.463 from CNY 0.357, reflecting a rise of 29.6%[22] Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥1,113,971,720.38, up 27.39% from the end of the previous year[4] - Total assets reached CNY 1,113,971,720.38, compared to CNY 874,431,397.93 in the previous year, indicating a growth of 27.4%[20] - Total current assets as of September 30, 2021, amount to ¥315,857,931.51, a significant increase from ¥130,327,543.12 at the end of 2020[18] - Total liabilities as of September 30, 2021, are ¥293,382,358.41, an increase from ¥259,460,425.17 at the end of 2020[19] - The total liabilities rose from CNY 259,460,425.17 to CNY 282,241,073.92, indicating an increase of about 8.8%[28] - The company's non-current liabilities increased from CNY 117,944,754.87 to CNY 140,725,403.62, marking a rise of approximately 19.3%[28] Equity and Shareholder Information - The company's total equity attributable to shareholders increased by 33.44% to ¥820,589,361.97 compared to the previous year[4] - The total equity attributable to shareholders increased to CNY 820,589,361.97, up 33.5% from CNY 614,970,972.76 year-on-year[20] - The largest shareholder, Wei Xiaoming, holds 42.64% of shares, totaling 79,960,000 shares[15] - Total number of common shareholders at the end of the reporting period is 26,449[15] Cash Flow - The cash flow from operating activities for the year-to-date was ¥132,155,681.82, reflecting a 56.13% increase[3] - Cash flow from operating activities generated a net amount of CNY 132,155,681.82, up 56.1% from CNY 84,645,074.63 in the prior year[24] - The company reported a significant increase in cash flow from financing activities, totaling ¥138,541,105.29, a 144.10% increase year-on-year[11] - The cash flow from financing activities showed a net inflow of CNY 138,541,105.29, compared to CNY 56,755,740.98 in the previous period, representing a significant increase[25] Other Income and Expenses - The company received government subsidies amounting to ¥7,018,378.80 during the reporting period, contributing to the increase in other income[5] - The company reported a significant increase in other income, which rose to CNY 13,621,400.00 from CNY 1,297,501.00, marking a substantial growth[21] - Research and development expenses were CNY 17,417,064.73, slightly up from CNY 16,346,020.96, indicating continued investment in innovation[20] Cash and Cash Equivalents - The company has seen a substantial increase in its cash and cash equivalents, which rose by 381.29% to ¥209,524,624.18 compared to the end of the previous year[7] - Cash and cash equivalents increased to ¥209,524,624.18 from ¥43,533,663.01 at the end of 2020[17] - The total cash and cash equivalents at the end of the period reached CNY 209,524,624.18, an increase of CNY 165,990,961.17 compared to the previous period[25] Operational Commitments and Future Plans - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[23] - The company has ongoing rental agreements with various entities, indicating a long-term commitment to its operational infrastructure[29] Audit and Reporting - The third-quarter report was not audited, which may affect the reliability of the financial data presented[31]

Financial Performance - The company's operating revenue for the first half of 2021 was CNY 354,267,032.13, representing a 26.12% increase compared to CNY 280,888,542.76 in the same period last year[22]. - The net profit attributable to shareholders of the listed company reached CNY 51,951,316.04, a significant increase of 61.23% from CNY 32,222,123.42 in the previous year[22]. - The net cash flow from operating activities was CNY 91,004,778.55, which is a remarkable increase of 210.74% compared to CNY 29,286,696.49 in the same period last year[22]. - The basic earnings per share increased to CNY 0.33, up 43.48% from CNY 0.23 in the previous year[22]. - Total assets at the end of the reporting period were CNY 1,074,650,586.41, reflecting a 22.90% increase from CNY 874,431,397.93 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company increased to CNY 795,473,822.06, a 29.35% rise from CNY 614,970,972.76 at the end of the previous year[22]. - The weighted average return on net assets was 7.53%, an increase of 1.98% compared to 5.55% in the previous year[22]. - The net profit after deducting non-recurring gains and losses was CNY 43,317,905.63, which is a 29.35% increase from CNY 33,489,372.93 in the same period last year[22]. Business Operations - The main business involves breeding and selling parent and grandparent generation egg-laying chickens, with a focus on technology development and service[28]. - The company operates three high-standard ecological breeding bases and has established 7 breeding divisions and 5 hatcheries across various regions[28]. - The procurement of grandparent generation chicks is conducted through a long-term strategic partnership with a global breeding company, ensuring a stable supply[32]. - The production model includes independent breeding and hatching processes, with a focus on biosecurity and product quality through a "full network high bed flat breeding" approach[30]. - The company employs a direct sales and distribution model, providing technical guidance and services to customers to enhance product promotion[30]. - The feed production is managed in-house, with a focus on controlling procurement risks and ensuring product quality through centralized bidding[33]. - The company has implemented a comprehensive internal control system for procurement and production management to enhance operational efficiency[33]. - The production process includes a detailed plan for egg allocation and hatching, ensuring a streamlined supply chain for chick production[35]. Market and Industry Trends - In 2021, China's poultry egg production decreased by 4.1% year-on-year to 15.57 million tons, with egg prices increasing by 9.3%[46]. - The number of breeding hens in China is expected to remain at around 15 million sets for parent stock, with an estimated 1.1 to 1.2 billion commercial layer chicks added in 2021[47]. - The introduction of the National Egg Chicken Genetic Improvement Plan (2021-2035) aims to establish a commercial breeding system by 2035, enhancing breeding technology to international advanced levels[47]. - The egg chicken breeding industry in China is characterized by a low overall concentration, with approximately 700 single-generation breeding enterprises, which are gradually decreasing[50]. - Major retailers and food companies in Europe are committing to sourcing only cage-free eggs by 2027, reflecting a significant shift in consumer preferences and regulatory changes[45]. - The EU has mandated the elimination of cage farming for egg-laying hens by 2027, responding to consumer demands for animal welfare and food quality[45]. - The overall profitability of egg chicken farming in China was negative in 2020 due to high feed costs and oversupply, impacting the willingness of small-scale farmers to enter the market[46]. - The egg chicken industry is transitioning from quantity growth to quality and efficiency, supported by national policies and structural reforms in agriculture[51]. Research and Development - Two key R&D projects were initiated under the Ningxia Hui Autonomous Region's key R&D plan, and two invention patents were applied for[39]. - The company has established a robust biosecurity system, with no major infectious diseases reported since its inception, enhancing its disease prevention capabilities[82]. - The company has built a strong R&D team focused on egg chicken breeding technology, with a comprehensive technical support system in place[88]. - The company has developed core technologies in breeding, hatching, and feed formulation, enhancing its competitive edge in the market[91]. - The company has established effective customer feedback mechanisms to address quality disputes and improve service quality[86]. Financial Management - Operating costs rose to ¥245,983,467.65, a 28.87% increase compared to the previous year, primarily driven by higher sales volume[107]. - Research and development expenses decreased by 19.67% to ¥9,708,047.73, as some projects were initiated later in the year[108]. - The company's cash and cash equivalents increased significantly by 16,510.85% to ¥157,482,968.56, mainly due to new share issuance[108]. - The total amount of funds raised was ¥147,302,133.26, with ¥35,105,941.43 invested during the reporting period[114]. - The company's gross profit margin for chicken sales was 30.37%, a decrease of 2.97% compared to the previous year[109]. Risks and Challenges - The company faces several risks, including poultry disease risks and reliance on foreign suppliers for egg-laying chickens[6]. - The company faces significant risks from avian diseases, which could severely impact production and operational performance[128]. - Fluctuations in raw material prices, particularly corn and soybean meal, could lead to increased production costs and decreased profit margins[129]. - The chicken egg market is subject to frequent price volatility due to macroeconomic factors, seasonal changes, and public health events[130]. - Dependency on foreign suppliers for high-quality breeding stock poses a risk, particularly with reliance on a single supplier, Aviagen[132]. - The COVID-19 pandemic has adversely affected operations, leading to transportation issues and decreased consumer demand for poultry products[133]. Corporate Governance and Social Responsibility - The company has actively participated in social responsibility initiatives, contributing a total of CNY 1.0497 million to poverty alleviation and rural revitalization efforts[152]. - The company has established a regular monitoring plan for environmental pollutants and has ensured compliance with emission standards through third-party assessments[150]. - The company has maintained a good integrity status, with no administrative or criminal penalties imposed during the reporting period[163]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[156]. - The company has not reported any significant changes in its financial situation or major risks during the reporting period[179].